Tenax Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -256.3% | -256.3% | -188.2% |
| FY2017 | -99.5% | -99.5% | -89.4% |
| FY2018 | -120.2% | -120.2% | -106.0% |
| FY2019 | -222.5% | -222.5% | -131.9% |
| FY2020 | -213.0% | -213.0% | -143.4% |
| FY2021 | -765.1% | -765.1% | -541.9% |
| FY2022 | 740.0% | 740.0% | 324.5% |
| FY2023 | -95.2% | -95.2% | -66.0% |
| FY2024 | -19.1% | -19.1% | -18.2% |
| FY2025 | -54.2% | -54.2% | -50.5% |